Showing 30 of 3541 posts
Inchcape acquires Silver Star in Bulgaria for £240m revenue, adding Mercedes-Benz & trucks. Margin-accretive, but price undisclosed. A smart bolt-on?
JoshuaMay 22, 2026
Metals Exploration FY2025: record revenue & free cash flow despite lower gold output. La India construction 50% complete, first gold due Dec 2026. Debt-free.
JoshuaMay 22, 2026
Softcat upgrades full-year profit guidance after strong Q3, driven by AI demand and memory shortages. Mid-teens growth expected.
JoshuaMay 22, 2026
Games Workshop reports core revenue up 10.6%, but licensing plummets 42.9%, leaving PBT barely higher at £265m.
JoshuaMay 22, 2026
Helical's annual results: a £333M office sale, £17M capital return, and improved lettings at The Bower. Strong progress despite lower profit.
JoshuaMay 22, 2026
Hercules PLC reports record revenue and underlying profit, but a qualified audit opinion on supplier controls casts a shadow over FY2025 results.
JoshuaMay 22, 2026
Sound Energy’s 2025 results: Tendrara LNG progress and new ventures, but going concern warning and thin cash keep risk high.
JoshuaMay 22, 2026
Creo Medical FY25: revenue up 50% to £6.0m, losses narrowing, but funding uncertainty remains with going concern warning.
JoshuaMay 22, 2026
STS Global Income & Growth Trust posts negative returns but cuts costs, grows dividend, and maintains discount control.
JoshuaMay 19, 2026
Currys profits beat guidance at £191m, with 18% growth and steady sales. A solid update that strengthens the investment case.
JoshuaMay 19, 2026
Renew Holdings acquires EDES for up to £9m to expand high voltage engineering capabilities. The bolt-on deal is immediately earnings enhancing and taps into £50-60bn UK grid investment.
JoshuaMay 19, 2026
IXICO reports strong H1 2026: revenue up 23%, gross margin 53.2%, order book £18.1m. Cash burn addressed with £10m fundraise. TechBio strategy unveiled.
JoshuaMay 19, 2026
Luceco's Q1 2026: 11% organic revenue growth, EV charging +80%, and profit guidance upgraded to >£40m. Strong momentum across the board.
JoshuaMay 19, 2026
C&C Group's FY2026 revenue fell but branded drinks grew; strategic shift to two engines aims to boost growth and margin recovery.
JoshuaMay 19, 2026
IG Group upgrades full-year guidance after strong Q1, with revenue up 19% and accelerating customer growth – a clear positive for investors.
JoshuaMay 19, 2026
Caledonia Investments posts 5.4% NAV return but -7.1% TSR amid 43.4% discount. Stonehage Fleming sale and dividend growth are highlights.
JoshuaMay 19, 2026
Victorian Plumbing H1 2026: double-digit revenue growth driven by tiles & flooring. Record orders, core profit up, but MFI investment weighs on profits.
JoshuaMay 19, 2026
discoverIE acquires 3Gmetalworx for £50m, strengthening its North American security and defence electronics presence with an immediately accretive deal.
JoshuaMay 19, 2026
Hilton Foods holds full-year guidance at £60m-£65m, with core meat trading strong but seafood and vegan divisions still challenging.
JoshuaMay 19, 2026
React Group H1 results: revenue up 9% to £13.2m, adjusted EBITDA +7%, free cash flow surges. Solid step forward, statutory loss narrows.
JoshuaMay 19, 2026
Water Intelligence Q1 revenue up 9%, B2B insurance and property management growth accelerates as preventive maintenance strategy gains momentum.
JoshuaMay 19, 2026
Topps Tiles outperforms a weak market with self-help measures driving profit progress, despite statutory profit dip.
JoshuaMay 19, 2026
DCC's annual results show strong adjusted profits and cash flow. Proposed name change to DCC Energy plc signals sharper strategic focus.
JoshuaMay 19, 2026
SSP Group H1 2026: sales up 6.2%, profits rise, dividend lifted, and full-year guidance held despite Middle East disruption. Solid, not spectacular.
JoshuaMay 19, 2026
Winvia Entertainment delivers strong FY25 revenue and EBITDA growth, but comparatives need care. Prize draw subscriptions and B2B gaming shine, though regulation remains a key watch.
JoshuaMay 19, 2026
Jadestone Energy posts record production & lower costs in 2025, but a US$110.7m loss from impairments and 2026 operational delays cloud the outlook.
JoshuaMay 19, 2026
Dr. Martens FY26 results: adjusted PBT surges 61% despite slight revenue dip – a genuine turnaround in margins, cash & debt.
JoshuaMay 19, 2026
Avacta’s FY25 results: pure-play oncology progress with pre|CISION platform, but funding risk remains. Next clinical data crucial.
JoshuaMay 19, 2026
EMV Capital's 2025 results show AUM up 14% to £112.5M and losses narrow 83%, but cash remains tight with a going concern warning.
JoshuaMay 19, 2026